Bal Krishan Saini designated as Senior Management Personnel of Panacea Biotec Pharma

Written By :  Ruchika Sharma
Published On 2025-11-14 09:00 GMT   |   Update On 2025-11-14 09:01 GMT
Advertisement

New Delhi: Panacea Biotec has announced that Bal Krishan Saini, Senior Vice President - Head Pharma Plant Operations & Corporate Project and Engineering Head has been designated as the Senior Management Personnel of the Company’s material wholly owned subsidiary, Panacea Biotec Pharma Limited.

Bal Krishan Saini has over 30 plus years of extensive experience in Engineering, Projects and Operations and had successfully led site Engineering, project, operations and plant management in USFDA / MHRA / WHO-compliant facilities, particularly in sterile injectable and formulation manufacturing.
Advertisement
He holds a Six Sigma Black Belt, leadership management training from ISB, cGMP training, and advanced degrees including M. Tech and PG Diploma in Environmental Health and Occupational Safety.
Prior to his joining, he was acting as Director (VP) – Operations at Emcure Pharmaceuticals Ltd., leading multiplants sterile and OSD manufacturing facilities, overseeing production, engineering, warehousing, and EHS. He has also held several positions at various companies including Akorn India, Wockhardt Ltd. and Unichem Laboratories Ltd.

Read also: Panacea Biotec receives award notification from PAHO for Easyfive-TT Vaccine supply

Panacea Biotec is a Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals and Vaccines.

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited. It got publically listed on Indian National Stock Exchanges in September 1995 as Panacea Biotec Ltd. The international pharmaceutical formulations product portfolio includes innovative prescription products in niche therapeutic areas such as Pain, Diabetes & Cardiovascular management, Oncology, Renal Disease, Osteoporosis management and Gastro-intestinal care. 

Read also: Panacea Biotec, Apotex resolve dispute over breach of collaboration agreement

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News